Imipenem + Cilastatin IV bulk supplier for pharma manufacturers

Imipenem + Cilastatin IV Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Solutions

Available Strengths: 500 mg/500 mg, 1 g/1 g per vial

Reference Brands: Primaxin, Gemax (US & EU)

Imipenem + Cilastatin inhibits bacterial cell wall synthesis by targeting penicillin-binding proteins, resulting in bacterial lysis. Cilastatin prevents renal degradation of imipenem, prolonging its activity. Benefits include rapid, broad-spectrum action against resistant bacteria, effective in severe infections like pneumonia and sepsis, with reliable bacterial eradication when used appropriately in clinical settings.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Imipenem + Cilastatin IV? List it or send an offer →

Product Description: Imipenem + Cilastatin intravenous (IV) is approved in both the EU and US for serious bacterial infections, including pneumonia, intra-abdominal, and urinary tract infections. In the EU, brands like Primaxin are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical trial data; generic formulations are widely available. Both regions require comprehensive dossiers, including trial results, quality controls, and pharmacovigilance plans, for approval and safety monitoring. We facilitate seamless market access ensuring adherence to European and US standards for effective, safe antibacterial therapy.

Imipenem + Cilastatin IV — third party manufacturing & bulk supply

Imipenem + Cilastatin IV is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Imipenem + Cilastatin IV is supplied as Intravenous (IV) Solutions — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Imipenem + Cilastatin IV listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Imipenem + Cilastatin IV →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Imipenem + Cilastatin IV is listed as Intravenous (IV) Solutions in 500 mg/500 mg, 1 g/1 g per vial. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Imipenem + Cilastatin IV is referenced against Primaxin, Gemax (US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.